In this review, I discuss three recent papers, adding to the role of minimally invasive glaucoma surgery (MIGS) in the management of glaucoma, particularly with respect to long-term efficacy and safety data.
Celebrating 25 years with Alcon, Karen Fowler worked her way up to become head of the Australia and New Zealand business and the region’s surgical division. As one of the few women holding top spots in the ophthalmic industry, she talked to Lesley Springall about the challenges and highlights of her
This year’s Orthoptics Australia Annual Conference took place virtually, so I got to enjoy the array of talks during a visit to my hometown of Hobart, with an interactive Slack channel providing an opportunity to engage with other attendees and see the various locations they were joining from.
A Canadian study has shown cannabinol (CBN) promotes neuroprotection, abrogates changes in extracellular matrix (ECM) protein and normalises intraocular pressures (IOPs), indicating the compound’s therapeutic potential in the treatment of glaucoma, said study authors.
Keratoconus appears both more common and more severe in Aotearoa than in many other countries and it has been the most common indication for corneal transplantation in New Zealand for several decades. Collagen corneal cross-linking (CXL) provides the opportunity to halt or slow the progression of ke
For previous Australia New Zealand Glaucoma Society conference (ANZGS) meetings I have enjoyed jetting off to Brisbane for a couple of days to be immersed in the humidity of Queensland in February. This year, I swapped educating myself sitting in the air-conditioned ballroom of some fancy Queensland
In my first article in February, I explained that while accessibility is the right thing to do, it is also the smart thing to do – embracing accessibility provides an opportunity to grow your business through tapping into what we at Be.Lab call ‘the access market’. Here, I look at ways to make simpl
Ocular melanoma (OM) is the most common cancer in the adult eye. OM affects structures in the eye containing melanocytes: the choroid, ciliary body, iris (collectively called the uvea) and the
The RANZCO Practice Managers’ Conference was the first full online conference I have attended, so I was a little dubious about how it would go. Traveling to Brisbane for a long weekend and networking with likeminded people sounded so much more appealing than giving up a weekend to sit at home with a
Non-melanoma skin cancers (NMSCs) are the commonest cancers in Australia and New Zealand. In 2006, the age-standardised incidence of NMSCs was 406 per 100,000 population in New Zealand1. Treatment of NMSCs represents a significant cost to Australasian healthcare systems1,2 and their incidence is ris
Focusing on dry eye disease (DED), the third Ocular Therapeutics Evening (OTE) finally went ahead after a five-month wait. It’s been a while since we had an in-person meeting, so it was great to see at least the top halves of some familiar faces again! It was also entertaining to see the Covid trace
